Moneycontrol
    Moneycontrol PRO
    Loans
    Loans

    Jump to

    • Accumulate Aurobindo Pharma; target of Rs 1065: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 1065 in its research report dated November 11, 2023.

    • Neutral Aurobindo Pharma; target of Rs 970: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 970 in its research report dated November 11, 2023.

    • Accumulate Aurobindo Pharma; target of Rs 907: KR Choksey

      KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 907 in its research report dated August 24, 2023.

    • Neutral Aurobindo Pharma; target of Rs 910: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 910 in its research report dated August 14, 2023.

    • Accumulate Aurobindo Pharma; target of Rs 900: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 900 in its research report dated August 14, 2023.

    • Hold Aurobindo Pharma; target of Rs 665: KR Choksey

      KR Choksey recommended hold rating on Aurobindo Pharma with a target price of Rs 665 in its research report dated May 31, 2023.

    • Hold Aurobindo Pharma; target of Rs 716: Sharekhan

      Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 716 in its research report dated May 30, 2023.

    • Neutral Aurobindo Pharma; target of Rs 600: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023.

    • Buy Aurobindo Pharma; target of Rs 660: Prabhudas Lilladher

      Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 660 in its research report dated May 29, 2023.

    • Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated February 10, 2023.

    • Hold Aurobindo Pharma; target of Rs 516: Sharekhan

      Sharekhan recommended hold rating on Aurobindo Pharma with a target price of Rs 516 in its research report dated February 10, 2023.

    • Buy Aurobindo Pharma; target of Rs 554: Geojit

      Geojit is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 554 in its research report dated March 02, 2023.

    • Buy Aurobindo Pharma; target of Rs 565: Prabhudas Lilladher

      Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 565 in its research report dated February 11, 2023.

    • Accumulate Aurobindo Pharma; target of Rs 550: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 550 in its research report dated November 16, 2022.

    • Neutral Aurobindo Pharma; target of Rs 500: Motilal Oswal

      Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 500 in its research report dated November 14, 2022.

    • Hold Aurobindo Pharma; target of Rs 540: ICICI Direct

      ICICI Direct recommended hold rating on Aurobindo Pharma with a target price of Rs 540 in its research report dated November 14, 2022.

    • Accumulate Aurobindo Pharma; target of Rs 626: KR Choksey

      KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 626 in its research report dated August 18, 2022.

    • Accumulate Aurobindo Pharma; target of Rs 635: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 635 in its research report dated August 15, 2022.

    • Hold Aurobindo Pharma; target of Rs 640: Sharekhan

      Sharekhan recommended hold rating on Aurobindo Pharma with a target price of Rs 640 in its research report dated August 12, 2022.

    • Hold Aurobindo Pharma; target of Rs 615: ICICI Direct

      ICICI Direct recommended hold rating on Aurobindo Pharma with a target price of Rs 615 in its research report dated August 12, 2022.

    • Buy Aurobindo Pharma; target of Rs 875: Sharekhan

      Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 875 in its research report dated February 10, 2022.

    • Accumulate Aurobindo Pharma; target of Rs 759: Prabhudas Lilladher

      Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 759 in its research report February 10, 2022.

    • Accumulate Aurobindo Pharma; target of Rs 756: KR Choksey

      KR Choksey recommended accumulate rating on Aurobindo Pharma with a target price of Rs 756 in its research report dated February 11, 2022.

    • Will the Street reward Aurobindo Pharma’s bet on domestic formulations?

      The Aurobindo Pharma stock currently trades at a valuation of 6.6x FY23e EV/EBITDA, which is at a substantial discount to its Indian peers with an exposure in the US market

    • Buy Aurobindo Pharma; target of Rs 915: Sharekhan

      Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 915 in its research report dated August 13, 2021.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347